Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Seminars in Dialysis|June 16, 2009
Endogenous and exogenous vasopressin during hemodialysisAliza M Thompson, Juan A OliverBlood Pressure Monitoring|July 13, 2007
Validation of an oscillometric home blood pressure monitor in an end-stage renal disease population and the effect of arterial stiffness on its accuracyAliza M Thompson, Kazuo Eguchi, Michael E Reznik, et al.Clinical Journal of the American Society of Nephrology : CJASN|July 26, 2017
FDA Regulatory Perspectives for Studies on Hemodialysis Vascular AccessFrank P Hurst, Robert E Lee, Aliza M Thompson, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 3, 2019
Addressing the Need for Clinical Trial End Points in Autosomal Dominant Polycystic Kidney Disease: A Report From the Polycystic Kidney Disease Outcomes Consortium (PKDOC)Kimberly A Smith, Aliza M Thompson, David A Baron, et al.Circulation|April 14, 2025
Patient-Reported Outcomes as End Points in Heart Failure TrialsJaved Butler, Muhammad Shariq Usman, Charu Gandotra, et al.Clinical Journal of the American Society of Nephrology : CJASN|September 28, 2016
Glomerular Diseases: Registries and Clinical TrialsMarva M Moxey-Mims, Michael F Flessner, Lawrence Holzman, et al.Glomerular Diseases|March 17, 2025
Designing Clinical Trials for the Treatment of Membranous Nephropathy in the Anti-Phospholipase A2 Receptor 1 Era: Results of a NephCure Membranous Nephropathy WorkshopMarco Prunotto, Patrick H Nachman, Barbara S Gillespie, et al.Kidney International|March 15, 2025
Designing clinical trials for the treatment of membranous nephropathy in the anti-PLA2R era: results of a Nephcure membranous nephropathy workshopMarco Prunotto, Patrick H Nachman, Barbara S Gillespie, et al.Clinical Pharmacology and Therapeutics|January 7, 2021
Evaluating Patients With Impaired Renal Function During Drug Development: Highlights From the 2019 US FDA Pharmaceutical Science and Clinical Pharmacology Advisory Committee MeetingMartina D Sahre, Lauren Milligan, Rajanikanth Madabushi, et al.Circulation. Cardiovascular Quality and Outcomes|October 5, 2020
Comparative Effectiveness and Safety of Oral Anticoagulants Across Kidney Function in Patients With Atrial FibrillationXiaoxi Yao, Jonathan W Inselman, Joseph S Ross, et al.Pageof 2